Lexicon Pharma (LXRX) Tops Q2 EPS by 11c
Tweet
Share
E-mail
Get Alerts LXRX Hot Sheet
Price: $2.35 --0%
Financial Fact:
Consolidated net loss: -36.02M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Consolidated net loss: -36.02M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Lexicon Pharma (NASDAQ: LXRX) reported Q2 EPS of ($0.33), $0.11 better than the analyst estimate of ($0.44). Revenue for the quarter came in at $12.1 million versus the consensus estimate of $18.34 million.
For earnings history and earnings-related data on Lexicon Pharma (LXRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
- NextPlat Corp (NXPL) Reports Q2 Loss of $0.05
- Melco Resorts & Entertainment (MLCO) Misses Q2 EPS by 7c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
